BioSpace News Archive

TherapeuticsMD, Inc., an innovative women’s healthcare company, announced that it will report its first quarter 2020 financial results on Wednesday, May 6, 2020, before the opening of the U.S. financial markets.

Inspire Medical Systems, Inc., a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced that it will release financial results for the first quarter 2020 after the close of trading on Tuesday, May 5.

Dr. Alberico Sessa Decreases Facelift Scarring And Recovery Time With Revolutionary SmartLift™.

Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with disabling and potentially fatal neuropsychiatric disorders and pain, announced the appointment of Christopher J. Coughlin to its board of directors.

Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced the submission of two Pre-Market Approval applications for MI Exome™ CDx and MI Transcriptome™ CDx to the U.S. Food and Drug Administration.

The objective of the trial is to evaluate the efficacy and safety of plitidepsin in patients with COVID-19 requiring hospital admission

The designation is for L‑CsA‑i for the treatment of bronchiolitis obliterans syndrome, developed by Breath Therapeutics, a Zambon company.

Eagle Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Ltd. announced that on April 27, 2020, the U.S. District Court for the District of Delaware has issued a patent decision in favor of Eagle and Teva for BENDEKA®, a liquid, low-volume and short-time 10-minute infusion formulation of bendamustine hydrochloride..

Talicia® is the first and only FDA-approved rifabutin-based therapy for H. pylori infection, designed as a first-line option to address the high resistance of H. pylori bacteria to standard-of-care therapies

Antares Pharma, Inc. announced it will release its first quarter 2020 financial results and recent operating progress before the market opens on Tuesday, May 5, 2020.